Evidence map›Paper›PMID 20639202›Full record

ArticleThe Journal of biological chemistry2010

Adenosine A2A receptor signaling and golf assembly show a specific requirement for the gamma7 subtype in the striatum.

William F Schwindinger, Lauren J Murphree Mihalcik, Kathryn E Giger, Kelly S Betz, Anna Maria Stauffer, Joel Linden, Denis Herve, Janet D Robishaw

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. The Signaling and Pharmacology of the Dopamine D1 Receptor.Frontiers in cellular neuroscience · 2021
    Pooled it
  2. Article
  3. Adenosine in the Brain: Recent Progress on Detection, Function, and Translation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. AInternational journal of molecular sciences · 2022
    Review
  12. Pathophysiological Role and Medicinal Chemistry of AMolecules (Basel, Switzerland) · 2022
    Review
  13. ACurrent medicinal chemistry · 2022
    Review
  14. Selective Manipulation of G-Protein γThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. GPCR regulation of secretion.Pharmacology & therapeutics · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

William F SchwindingerWeis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822, USA.
Lauren J Murphree Mihalcik
Kathryn E Giger
Kelly S Betz
Anna Maria Stauffer
Joel Linden
Denis Herve
Janet D Robishaw
Geisinger Medical Center · USInserm · FRInstitut du Fer à Moulin · FRLa Jolla Institute for Immunology · US

Funding

Purification & Characterization of Adenosine ReceptorsR01HL037942 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDEN, JOEL M. · 1986 to 2009
$3.1M
G PROTEIN--SIGNIFICANCE OF B &Y SUBUNIT HETEROGENEITYR01GM039867 · NIGMS · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI ROBISHAW, JANET D · 1993 to 2010
$3.1M
G PROTEINS:SIGNIFICANCE OF B AND Y SUBUNIT HETEROGENEITYR29GM039867 · NIGMS · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI ROBISHAW, JANET D · 1988 to 1992
–
PURIFICATION AND CHARACTERIZATION OF ADENOSINE RECEPTORSR55HL037942 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDEN, JOEL M. · 1991 to 1991
–
NHLBI NIH HHS HL37942NHLBI NIH HHS R01 HL037942NIGMS NIH HHS GM39867NIGMS NIH HHS R01 GM039867
6 · The paper itself

Abstract

The adenosine A(2A) receptor (A(2A)R) is increasingly recognized as a novel therapeutic target in Parkinson disease. In striatopallidal neurons, the G-protein α(olf) subtype is required to couple this receptor to adenylyl cyclase activation. It is now well established that the βγ dimer also performs an active role in this signal transduction process. In principal, sixty distinct βγ dimers could arise from combinatorial association of the five known β and 12 γ subunit genes. However, key questions regarding which βγ subunit combinations exist and whether they perform specific signaling roles in the context of the organism remain to be answered. To explore these questions, we used a gene targeting approach to specifically ablate the G-protein γ(7) subtype. Revealing a potentially new signaling paradigm, we show that the level of the γ(7) protein controls the hierarchial assembly of a specific G-protein α(olf)β(2)γ(7) heterotrimer in the striatum. Providing a probable basis for the selectivity of receptor signaling, we further demonstrate that loss of this specific G-protein heterotrimer leads to reduced A(2A)R activation of adenylyl cyclase. Finally, substantiating an important role for this signaling pathway in pyschostimulant responsiveness, we show that mice lacking the G-protein γ(7) subtype exhibit an attenuated behavioral response to caffeine. Collectively, these results further support the A(2A)R G-protein α(olf)β(2)γ(7) interface as a possible therapeutic target for Parkinson disease.

Indexed as

AnimalsBehavior, AnimalCaffeineCentral Nervous System StimulantsCorpus StriatumGTP-Binding Protein alpha SubunitsGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsMiceMice, Inbred BALB CMice, KnockoutMultienzyme ComplexesParkinson DiseaseReceptor, Adenosine A2ASignal TransductionCaffeineCentral Nervous System StimulantsGTP-Binding Protein alpha SubunitsGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsMultienzyme ComplexesReceptor, Adenosine A2A

Identifiers

PMID20639202
PMCPMC2943273
OpenAlexW2007251619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.